Analyst Favorites With Strong Buyback Activity: Ligand Pharmaceuticals Ranks As a Top Pick

A study of analyst recommendations at the major brokerages shows that Ligand Pharmaceuticals Inc (LGND) is the #64 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.